Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Optics Express|June 12, 2008
Size-dependent optical properties of BaTiO3-SrTiO3 superlatticesJ Hiltunen, J Lappalainen, J Puustinen, et al.
American Journal of Medical Genetics|April 24, 1995
Mapping of the serotonin 5-HT1D beta autoreceptor gene on chromosome 6 and direct analysis for sequence variantsJ Lappalainen, M Dean, L Charbonneau, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1990
Chronic treatment with SCH 23390 and haloperidol: effects on dopaminergic and serotonergic mechanisms in rat brainJ Lappalainen, J Hietala, M Koulu, et al.
Clinical and Experimental Immunology|March 14, 2013
Intracellular RNA recognition pathway activates strong anti-viral response in human mast cellsJ Lappalainen, J Rintahaka, P T Kovanen, et al.
Environmental Pollution (Barking, Essex : 1987)|January 28, 2003
Assessing sediment toxicity and arsenite concentration with bacterial and traditional methodsT Petänen, M Lyytikäinen, J Lappalainen, et al.
Biological Psychiatry|September 24, 1999
HTR2C Cys23Ser polymorphism in relation to CSF monoamine metabolite concentrations and DSM-III-R psychiatric diagnosesJ Lappalainen, J C Long, M Virkkunen, et al.
Journal of Food Protection|March 4, 2000
Microbial testing methods for detection of residual cleaning agents and disinfectants-prevention of ATP bioluminescence measurement errors in the food industryJ Lappalainen, S Loikkanen, M Havana, et al.
Alimentary Pharmacology & Therapeutics|August 13, 2014
Randomised clinical trial: the long-term safety and tolerability of naloxegol in patients with pain and opioid-induced constipationL Webster, W D Chey, J Tack, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 17, 2010
Exposure to dogs is associated with a decreased tumour necrosis factor-α-producing capacity in early lifeM H J Lappalainen, K Huttunen, M Roponen, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 21, 2016
Population Exposure-Response Modeling of Naloxegol in Patients With Noncancer-Related Pain and Opioid-Induced ConstipationN Al-Huniti, J C Nielsen, M M Hutmacher, et al.
Pageof 5